Mechanistic Insights into the Adenosine A1 Receptor’s Positive Allosteric Modulation for Non-Opioid Analgesics
Cells · 2024
DOI: 10.3390/cells13242121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Tal Weizmann und 9 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Health and Life Sciences, Coventry University, Coventry CV1 5FB, UK. Hauptthemen laut MEDLINE: Receptor, Adenosine A1, Molecular Dynamics Simulation. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council, BBSCR, Royal Society Industry Fellowship.
Abstract (Originalsprache)
The adenosine A1 receptor (A1R) is a promising target for pain treatment. However, the development of therapeutic agonists is hampered by adverse effects, mainly including sedation, bradycardia, hypotension, or respiratory depression. Recently discovered molecules able to overcome this impediment are the positive allosteric modulator MIPS521 and the A1R-selective agonist BnOCPA, which are both potent and powerful analgesics with fewer side effects. While BnOCPA directly activates the A1R from the canonical orthosteric site, MIPS521 binds to an allosteric site, acting in concert with orthosteric adenosine and tuning its pharmacology. Given their overlapping profile in pain models but distinct mechanisms of action, we combined pharmacology and microsecond molecular dynamics simulations to address MIPS521 and BnOCPA activity and their reciprocal influence when bound to the A1R. We show that MIPS521 changes adenosine and BnOCPA G protein selectivity in opposite ways and propose a structural model where TM7 dynamics are differently affected and involved in the G protein preferences of adenosine and BnOCPA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Health and Life Sciences, Coventry University, Coventry CV1 5FB, UK.
- Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, UK.
- Institute of Biochemistry and Molecular Medicine, University of Bern, 3012 Bern, Switzerland.
ORCID-Profile: Achille Schild, Philipp Grossenbacher, Martin Lochner, Christopher A Reynolds, Graham Ladds, Giuseppe Deganutti
Förderung
- Biotechnology and Biological Sciences Research Council
- BBSCR
- Royal Society Industry Fellowship
Zitieren
APA
Weizmann, T., Pearce, A., Griffin, P., Schild, A., Flaßhoff, M., Grossenbacher, P., Lochner, M., Reynolds, C. A., Ladds, G., & Deganutti, G. (2024). Mechanistic Insights into the Adenosine A1 Receptor’s Positive Allosteric Modulation for Non-Opioid Analgesics. Cells. https://doi.org/10.3390/cells13242121
Vancouver
Weizmann T, Pearce A, Griffin P, Schild A, Flaßhoff M, Grossenbacher P, et al. Mechanistic Insights into the Adenosine A1 Receptor’s Positive Allosteric Modulation for Non-Opioid Analgesics. Cells. 2024. doi:10.3390/cells13242121
BibTeX
@article{Weizmann2024,
author = {Weizmann, Tal and Pearce, Abigail and Griffin, Peter and Schild, Achille and Flaßhoff, Maren and Grossenbacher, Philipp and Lochner, Martin and Reynolds, Christopher A and Ladds, Graham and Deganutti, Giuseppe},
title = {Mechanistic Insights into the Adenosine A1 Receptor’s Positive Allosteric Modulation for Non-Opioid Analgesics},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13242121}
}
EUVIMED